FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a low-toxicity pharmaceutical composition with anticancer activity on cholangiocarcinoma. Low-toxicity pharmaceutical composition with anticancer activity against cholangiocarcinoma is an oil solution containing ginsenosides Re, Rb2, Rg2, alpha-pinene, beta-pinene, beta-myrcene, 1,8-cineole, sabinene, rhodionine, quercetin, luteolin at the following content of components, mg/l: ginsenoside Re – 370–390, ginsenoside Rb2 – 330–350, ginsenoside Rg2 – 420–440, alpha-pinene – 240–260, beta-pinene – 200–220, beta-myrcene – 30–250, 1,8-cineole – 280–300, sabinene – 180–200, rhodionine – 380–400, quercetin – 480–500, luteolin – 440–460, vegetable oil – the rest.
EFFECT: composition described above has improved qualitative and quantitative composition, reduced toxicity and provides anticancer activity with respect to cholangiocarcinoma.
1 cl, 11 dwg, 6 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION EXHIBITING CYTOTOXICITY TOWARDS HUMAN COLON CARCINOMA CELLS | 2020 |
|
RU2747147C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING ANTIMUTAGENIC ACTION (VERSIONS) | 2012 |
|
RU2477142C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
SYNERGISTIC COMPOSITION OF VEGETABLE ORIGIN (VARIANTS), METHOD FOR TREATMENT OF DISEASES WITH ITS USING | 2005 |
|
RU2319494C2 |
IMPROVED TERPENE-BASED COMPOSITIONS, WAYS, METHODS OF PRODUCING AND CORRESPONDING PRODUCTS | 2014 |
|
RU2691986C2 |
AGENT FOR CANCER PROPHYLAXIS | 2002 |
|
RU2219935C1 |
INSECT REPELLENT COMPOSITION | 2020 |
|
RU2820472C2 |
ANTICANCER AGENT | 2014 |
|
RU2575572C1 |
AGENT FOR TREATING HORMONE-DEPENDENT TUMORS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2703533C1 |
TITANIUM IMPLANT WITH THE FUNCTION OF LOCAL IMMUNOTHERAPY FOR OSTEORECONSTRUCTIVE SURGERY AND PREVENTION OF LOCAL RECURRENCE OF ONCOLOGICAL DISEASE AND METHOD FOR ITS MANUFACTURE | 2021 |
|
RU2779367C1 |
Authors
Dates
2024-09-02—Published
2023-12-22—Filed